Compromise or capitulation? US Food and Drug Administration jurisdiction over tobacco products

PLoS Medicine

Volumn 6, Issue 7, 2009, Pages

  Glantz, Stanton A ^a   Barnes, Richard ^a   Eubanks, Sharon Y ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; ECONOMIC ASPECT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; LAW ENFORCEMENT; PROFIT; PUBLIC OPINION; REVIEW; SMOKING CESSATION; TOBACCO INDUSTRY; UNITED STATES;

HUMANS; NICOTINE; SMOKING; TOBACCO; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 68049117179     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000118     Document Type: Review

References (43)

1. Yang JS, Novotny TE (2009) Policy coherence in US tobacco control: Beyond FDA regulation. PLoSMed 6: e1000079. doi:10.1371/journal.pmed.1000079.
2. Givel M, Glantz SA (2004) The "global settlement" with the tobacco industry: 6 years later. Am J Public Health 94: 218-224.
3. Fox BJ, Lightwood JM, Glantz SA (1998) A public health analysis of the proposed resolution of [the 1997 United States] tobacco litigation. Available: http://repositories.cdlib.org/ctcre/tcpmus/US1998. Accessed 25 June 2009.
4. Wagner S (1971) Cigarette country; Tobacco in American history and politics. New York: Praeger.
5. Brandt AM (2007) The cigarette century. New York: Basic Books.
6. Borland R, Yong HH, Wilson N, Fong GT, Hammond D, et al. (2009) How reactions to cigarette packet health warnings influence quitting: Findings from the ITC four-country survey. Addiction 104: 669-675.
7. Campaign for Tobacco-Free Kids (2009) FDA regulation of tobacco products: A common-sense plan to protect kids and save lives. Available: http://www.lungusa.org/atf/cf/%7B7a8d42c2-fcca-4604-8ade-7f5d5e762256%7D/ FDA-BILL-SUMMARY.PDF. Accessed 25 June 2009.
8. US Department of Health and Human Services (1989) Reducing the health consequences of smoking: 25 years of progress. A Report of the Surgeon General. Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411. Available: http://profiles.nlm. nih.gov/NN/B/B/X/S/. Accessed 25 June 2009.
9. Siegel M, Carol J, Jordan J, Hobart R, Schoenmarklin S, et al. (1997) Preemption in tobacco control: Review of an emerging public health problem. JAMA 278: 858-863.
10. Novotny TE, Zhao F (1999) Consumption and production waste: Another externality of tobacco use. Tob Control 8: 75-80.
11. Barker KG (2009) Thank you for regulating: Why Philip Morris's embrace of FDA regulation helps the company but harms the agency. Admin Law Rev 61: 197-224.
12. McDaniel PA, Malone RE (2005) Understanding Philip Morris's pursuit of US government regulation of tobacco. Tob Control 14: 193-200.
13. McDaniel PA, Smith EA, Malone RE (2006) Philip Morris's Project Sunrise: Weakening tobacco control by working with it. Tob Control 15: 215-223.
14. Berlind MH (1998) Design, manufacturing and marketing of tobacco products: Towards a sensible regulatory framework. Philip Morris. Available: http://legacy.library.ucsf.edu/tid/lgs32a00. Accessed 25 June 2009.
15. Goldman L, Glantz S (1994) Evaluation of antismoking advertising campaigns. JAMA 279: 772-777.
16. Farrelly MC, Healton CG, Davis KC, Messeri P, Hersey JC, et al. (2002) Getting to the truth: Evaluating national tobacco countermarketing campaigns. Am J Public Health 92: 901-907.
17. Farrelly MC, Davis KC, Haviland ML, Messeri P, Healton CG (2005) Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence. Am J Public Health 95: 425-431.
18. Farrelly MC, Nonnemaker J, Davis KC, Hussin A (2009) The influence of the national truth campaign on smoking initiation. Am J Prev Med 36: 379-384.
19. Ling PM, Neilands TB, Glantz SA (2007) The effect of support for action against the tobacco industry on smoking among young adults. Am J Pub Health 97: 1449-1456.
20. Ling PM, Neilands TB, Glantz SA (2009) Factors associated with young adult smoking behavior: A national survey. Am J Prev Med 36: 389-394.
21. Giovino GA, Sidney S,Gfroerer JC,O'Malley PM, Allen JA, et al. (2004) Epidemiology of menthol cigarette use. Nicotine Tob Res 6: S67-S81.
22. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J (1996) The cigarette papers. Berkeley: University of California Press. pp 219-224.
23. United States District Court for the District of Columbia (2006) United States v. Philip Morris USA, Inc., et al. 449 F.Supp. 2d 1 (D.D.C. 2006). Available: http://library.ucsf.edu/tobacco/litigation/uspm.html. Accessed 25 June 2009.
24. Barnes D, Bero LA (1996) Industry-funded research and conflict of interest: An analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law 21: 515-542.
25. Barnes D, Bero LA (1997) Scientific quality of original research articles on environmental tobacco smoke. Tob Control 6: 19-26.
26. Barnes D, Bero LA (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279: 1566-1570.
27. Barnes D, Hanauer P, Slade J, Bero LA, Glantz S (1995) Environmental tobacco smoke. The Brown and Williamson documents. JAMA 274: 248-253.
28. Barnoya J, Glantz S (2002) Tobacco industry success in preventing regulation of secondhand smoke in Latin America: The "Latin Project". Tob Control 11: 305-314.
29. Barnoya J, Glantz S (2005) The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur J Public Health 16: 69-77.
30. Bero L (2003) Implications of the tobacco industry documents for public health policy. Annu Rev Public Health 24: 267-288.
31. Bero L (2005) Tobacco industry manipulation of research. Public Health Rep 120: 200-208.
32. Bero L, Galbraith A, Rennie D (1994) Sponsored symposia on environmental tobacco smoke. JAMA 271: 612-617.
33. Hirschhorn N, Bialous S (2001) Secondhand smoke and risk assessment: What was in it for the tobacco industry? Tob Control 10: 375-382.
34. Hong M-K, Bero LA (2002) How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ 325: 1413-1416.
35. Muggli ME, Forster J, Hurt RD, Repace J (2001) The smoke you don't see: Uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies. Am J Public Health 91: 1419-1423.
36. Ong E, Glantz S (2001) Constructing "sound science" and "good epidemiology": Tobacco, lawyers, and public relations firms. Am J Public Health 91: 1749-1757.
37. Schotland M, Bero LA (2002) Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk Anal 22: 131-140.
38. United States Court of Appeals (2009) U.S.A. v. Philip Morris, et al. No. 06-5267. Available: http://pacer.cadc.uscourts.gov/docs/common/opinions/200905/ 06-5267-1181914.pdf. Accessed 25 June 2009.
39. World Health Organization (2004) WHO framework convention on tobacco control. Available: http://www.who.int/fctc/en/index.html. Accessed 25 June 2009.
40. Framework Convention on Tobacco Control Conference of the Parties (2008) Guidelines for implementation of Article 5.3: Guidelines on the protection of public health policies with respect to tobacco control from commercial and other vested interests. Available: http://www.who.int/fctc/guidelines/article-5-3/en/ index.html. Accessed 25 June 2009.
41. Blalock J, Burgard J (1963) Re: Tobacco Institute, Tobacco Industry Research Committee, and Hill & Knowlton. Brown and Williamson Tobacco Corporation. Available: http://legacy.library.ucsf.edu/tid/akc72d00. Accessed 25 June 2009.
42. United States Supreme Court (1995) Rubin v. Coors Brewing Co., 514 U.S. 476. Available: http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl?court= us&vol=514&invol=476. Accessed 25 June 2009.
43. Szymanczyk M (2009) Letter to Henry Waxman endorsing Family Smoking Prevention and Tobacco Control Act. Available: http://energycommerce. house.gov/Press-111/20090304/hr1256-support.pdf. Accessed 25 June 2009.